Free Trial

Eli Lilly and Company (LLY) News Today

Eli Lilly and Company logo
$807.42
-11.51 (-1.41%)
(As of 03:09 PM ET)
Eli Lilly and Company stock logo
Eli Lilly and Company (NYSE:LLY) Stock Price Down 1.2% After Analyst Downgrade
Eli Lilly and Company (NYSE:LLY) Shares Down 1.2% After Analyst Downgrade
Eli Lilly and Company stock logo
Eli Lilly and Company (NYSE:LLY) Price Target Cut to $1,015.00 by Analysts at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft reduced their price target on Eli Lilly and Company from $1,025.00 to $1,015.00 and set a "buy" rating for the company in a report on Monday.
Eli Lilly and Company stock logo
QRG Capital Management Inc. Buys 1,980 Shares of Eli Lilly and Company (NYSE:LLY)
QRG Capital Management Inc. boosted its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 1.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,162 shares of the company's stock after buyin
Big Pharma's Obesity Bonanza Faces New Tests
Eli Lilly and Company Q3 Earnings Transcript
KFSHRC & Lilly Collaborate in Alzheimer's Early Detection
Eli Lilly and Company stock logo
Van ECK Associates Corp Increases Stock Holdings in Eli Lilly and Company (NYSE:LLY)
Van ECK Associates Corp raised its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 11.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 269,469 shares of the company's stock after purchasing an additional
Leerink Partnrs Has Negative Outlook of LLY FY2024 Earnings
Eli Lilly and Company stock logo
F M Investments LLC Sells 2,330 Shares of Eli Lilly and Company (NYSE:LLY)
F M Investments LLC trimmed its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 4.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 45,181 shares of the company's stock after selling 2,330 shares
Eli Lilly and Company stock logo
Eli Lilly and Company (NYSE:LLY) Stock Price Down 0.7% After Analyst Downgrade
Eli Lilly and Company (NYSE:LLY) Shares Down 0.7% Following Analyst Downgrade
Eli Lilly and Company stock logo
Principal Securities Inc. Purchases 1,027 Shares of Eli Lilly and Company (NYSE:LLY)
Principal Securities Inc. raised its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 7.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,189 shares of the company's stock after acquiring an add
Here Are the Next 3 Stock Splits to Keep on Your Radar
Eli Lilly and Company stock logo
Leerink Partnrs Issues Pessimistic Forecast for LLY Earnings
Eli Lilly and Company (NYSE:LLY - Free Report) - Research analysts at Leerink Partnrs dropped their FY2024 EPS estimates for Eli Lilly and Company in a research note issued to investors on Thursday, October 31st. Leerink Partnrs analyst D. Risinger now anticipates that the company will post earni
Eli Lilly and Company stock logo
Barclays Lowers Eli Lilly and Company (NYSE:LLY) Price Target to $975.00
Barclays decreased their price target on shares of Eli Lilly and Company from $1,025.00 to $975.00 and set an "overweight" rating on the stock in a research note on Thursday.
Eli Lilly and Company stock logo
Eli Lilly and Company (NYSE:LLY) Stock Price Down 1.9% After Earnings Miss
Eli Lilly and Company (NYSE:LLY) Shares Down 1.9% After Earnings Miss
Eli Lilly and Company stock logo
Burr Financial Services LLC Increases Stake in Eli Lilly and Company (NYSE:LLY)
Burr Financial Services LLC increased its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 50.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,806 shares of the compa
Viking Therapeutics weight loss pills
Viking Therapeutics Stock: A Pre-Election Bet Worth Considering (LLY)
Viking Therapeutics is making headway in the weight loss drug market; but even though the payoff is years away, there's still plenty of upside for investors
A person stands near an electronic stock board showing Japan's Nikkei index at a securities firm in…
Stock market today: Asia shares decline as investors await earnings, US elections and economic data
Asian shares are mostly declining amid uncertainty ahead of the United States presidential election next week
Financial markets news icon
How major US stock indexes fared Wednesday, 10/30/2024
U.S. stock indexes gave up an early gain and ended slightly lower following a mixed set of profit reports from giants like Google’s parent company and Eli Lilly
Eli Lilly: The Stock Might Have Peaked
Why Eli Lilly Stock Is Sinking Today
Eli Lilly and Company stock logo
Eli Lilly and Company (NYSE:LLY) Trading Down 6% After Earnings Miss
Eli Lilly and Company (NYSE:LLY) Shares Down 6% After Earnings Miss
Eli Lilly and Company stock logo
Eli Lilly and Company (NYSE:LLY) Updates FY24 Earnings Guidance
Eli Lilly and Company (NYSE:LLY) updated its FY24 earnings guidance. The company provided EPS guidance of $13.02-13.52 for the period, compared to the consensus estimate of $13.42. The company also issued revenue guidance of $45.4-46.0 billionillion, compared to the consensus estimate of $46.24 billionillion.
Eli Lilly and Company stock logo
Eli Lilly and Company (NYSE:LLY) Shares Gap Down Following Weak Earnings
Eli Lilly and Company (NYSE:LLY) Shares Gap Down on Disappointing Earnings
This April 26, 2017 file photo shows the Eli Lilly & Co
Drugmaker Eli Lilly walks back 2024 forecast after 3Q earnings miss
Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations
Eli Lilly and Company stock logo
Eli Lilly and Company (NYSE:LLY) Releases Quarterly Earnings Results, Misses Expectations By $0.35 EPS
Eli Lilly and Company (NYSE:LLY - Get Free Report) issued its earnings results on Wednesday. The company reported $1.18 EPS for the quarter, missing the consensus estimate of $1.53 by ($0.35). The firm had revenue of $11.44 billion during the quarter, compared to analyst estimates of $12.09 billion. Eli Lilly and Company had a net margin of 18.86% and a return on equity of 67.52%. Eli Lilly and Company's quarterly revenue was up 20.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.10 earnings per share.
Get Eli Lilly and Company News Delivered to You Automatically

Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter.

How high could Bitcoin go? (Ad)

Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”

Learn More Here

LLY Media Mentions By Week

LLY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LLY
News Sentiment

0.07

0.46

Average
Medical
News Sentiment

LLY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LLY Articles
This Week

84

42

LLY Articles
Average Week

Get Eli Lilly and Company News Delivered to You Automatically

Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:LLY) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners